-
1
-
-
0029866755
-
Age at menopause as a risk factor for cardiovascular mortality
-
DOI 10.1016/S0140-6736(96)90075-6
-
Van der Schouw Y, Van der Graaf Y, Steyerberg EW, Eijkemans MJC, Banga JD (1996) Age at menopause as a risk factor for cardiovascular mortality. Lancet 347:714-718 (Pubitemid 26085645)
-
(1996)
Lancet
, vol.347
, Issue.9003
, pp. 714-718
-
-
Van Der, S.Y.T.1
Van Der, G.Y.2
Steyerberg, E.W.3
Eijkemans, M.J.C.4
Banga, J.D.5
-
2
-
-
0029827353
-
Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women
-
McCrohon JA, Adams MR, McCredie RJ et al (1996) Hormone replacement therapy is associated with improved arterial physiology in healthy postmenopausal women. Clin Endocrinol 45:435-441 (Pubitemid 26383421)
-
(1996)
Clinical Endocrinology
, vol.45
, Issue.4
, pp. 435-441
-
-
McCrohon, J.A.1
Adams, M.R.2
McCredie, R.J.3
Robinson, J.4
Pike, A.5
Abbey, M.6
Keech, A.C.7
Celermajer, D.S.8
-
3
-
-
0028799383
-
Oestrogen replacement therapy and progression of intimal-thickness in the carotid arteries of postmenopausal women
-
Espeland MA, Applegate W, Furberg CD et al (1995) Oestrogen replacement therapy and progression of intimal-thickness in the carotid arteries of postmenopausal women. Am J Epidemiol 142:1011-1019
-
(1995)
Am J Epidemiol
, vol.142
, pp. 1011-1019
-
-
Espeland, M.A.1
Applegate, W.2
Furberg, C.D.3
-
4
-
-
0027446488
-
Isolated systolic hypertension and vessel wall thickness of the carotid artery: The Rotterdam Elderly Study
-
Bots ML, Hofman A, de Bruijn AM, de Jong PTVM, Grobbee DE (1993) Isolated systolic hypertension and vessel wall thickness of the carotid artery: The Rotterdam Elderly Study. Arterioscler Thromb 13:64-69 (Pubitemid 23021584)
-
(1993)
Arteriosclerosis and Thrombosis
, vol.13
, Issue.1
, pp. 64-69
-
-
Bots, M.L.1
Hofman, A.2
De Bruyn, A.M.3
De Jong, P.T.V.M.4
Grobbee, D.E.5
-
5
-
-
34247177716
-
Menopausal hormone therapy
-
Wenger NK, Collins P (eds) Taylor and Francis, London
-
Stevenson JC (2005) Menopausal hormone therapy. In: Wenger NK, Collins P (eds) Women and heart disease. Taylor and Francis, London, pp 375-390
-
(2005)
Women and Heart Disease
, pp. 375-390
-
-
Stevenson, J.C.1
-
6
-
-
32644436832
-
Conjugated equine estrogens and coronary heart disease
-
Hsia J, Langer RD, Manson ME et al (2006) Conjugated equine estrogens and coronary heart disease. Arch Intern Med 166:357-365
-
(2006)
Arch Intern Med
, vol.166
, pp. 357-365
-
-
Hsia, J.1
Langer, R.D.2
Manson, M.E.3
-
7
-
-
0141727785
-
Pharmacology of estradiol valerate/dienogest
-
Teichmann A (2003) Pharmacology of estradiol valerate/dienogest. Climacteric 6(Suppl. 2):17-23
-
(2003)
Climacteric
, vol.6
, Issue.SUPPL. 2
, pp. 17-23
-
-
Teichmann, A.1
-
8
-
-
0000275817
-
A comparative investigation of contraceptive reliability
-
Foidart JM, Wuttke W, Bouw GM, Gerlinger C, Heithecker R (2000) A comparative investigation of contraceptive reliability. Eur J Contracept Reprod Health Care 5:124-134
-
(2000)
Eur J Contracept Reprod Health Care
, vol.5
, pp. 124-134
-
-
Foidart, J.M.1
Wuttke, W.2
Bouw, G.M.3
Gerlinger, C.4
Heithecker, R.5
-
9
-
-
19744376817
-
Effects of drospirenone/17-β estradiol on blood pressure and potassium balance in hypertensive postmenopausal women
-
DOI 10.1016/j.amjhyper.2004.12.003, PII S0895706105000051
-
Preston RA, White WB, Pitt B et al (2005) Effects of drospirenone/17- β estradiol on blood pressure and potassium balance in hypertensive postmenopausal women. Am J Hypertens 18:797-804 (Pubitemid 40745265)
-
(2005)
American Journal of Hypertension
, vol.18
, Issue.6
, pp. 797-804
-
-
Preston, R.A.1
White, W.B.2
Pitt, B.3
Bakris, G.4
Norris, P.M.5
Hanes, V.6
-
10
-
-
0034711753
-
Essential hypertension. Part I. Definition and etiology
-
Carretero OA, Oparil S (2000) Essential hypertension. Part I. definition and etiology. Circulation 101:329-335
-
(2000)
Circulation
, vol.101
, pp. 329-335
-
-
Carretero, O.A.1
Oparil, S.2
-
11
-
-
0026518001
-
Assessment of the risk of postmenopausal osteoporosis using clinical risk factors
-
Oxf
-
Ribot C, Bonneu M, Pouillès J-M, Trèmollieres F (1992) Assessment of the risk of postmenopausal osteoporosis using clinical risk factors. Clin Endocrinol (Oxf) 36:225-258
-
(1992)
Clin Endocrinol
, vol.36
, pp. 225-258
-
-
Ribot, C.1
Bonneu, M.2
Pouillès, J.-M.3
Trèmollieres, F.4
-
12
-
-
0023002525
-
Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging
-
Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R (1986) Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74:1399-1406 (Pubitemid 17189260)
-
(1986)
Circulation
, vol.74
, Issue.6
, pp. 1399-1406
-
-
Pignoli, P.1
Tremoli, E.2
Poli, A.3
-
13
-
-
0023099735
-
Menopause and the risk of coronary heart disease in women
-
Colditz GA, Willet WC, Stampfer MJ, Rosner B, Spiezer FK, Hennekers CH (1987) Menopause and the risk of coronary heart disease in women. New Engl J Med 316:1105-1110 (Pubitemid 17052498)
-
(1987)
New England Journal of Medicine
, vol.316
, Issue.18
, pp. 1105-1110
-
-
Colditz, G.A.1
Willett, W.C.2
Stampfer, M.J.3
-
14
-
-
0025981467
-
Estrogen replacement and coronary heart disease: A quantitative assessment of the epidemiologic evidence
-
Stampfer MI, Colditz GA (1991) Estrogen replacement and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20:47-63
-
(1991)
Prev Med
, vol.20
, pp. 47-63
-
-
Stampfer, M.I.1
Colditz, G.A.2
-
15
-
-
0025755590
-
Estrogen and coronary artery disease in women
-
Barret-Connor E, Bush TL (1991) Estrogen and coronary artery disease in women. J Am Med Assoc 265:1861-1867
-
(1991)
J Am Med Assoc
, vol.265
, pp. 1861-1867
-
-
Barret-Connor, E.1
Bush, T.L.2
-
16
-
-
0035114767
-
Carotid artery intima thickness and flow velocity after discontinuation of hormone replacement therapy in postmenopausal women: Follow-up study
-
Vidovic IP, Demarin V, Grubisic G, Kuna K, Huzjan AL (2001) Carotid artery intima thickness and flow velocity after discontinuation of hormone replacement therapy in postmenopausal women: follow-up study. Croat Med J 42:54-57 (Pubitemid 32179064)
-
(2001)
Croatian Medical Journal
, vol.42
, Issue.1
, pp. 54-57
-
-
Pentz, V.I.1
Demarin, V.2
Grubisic, G.3
Kuna, K.4
Huzjan, A.L.5
-
17
-
-
67649939220
-
Hormone replacement therapy and cardiovascular disease revisited
-
Stevenson JC (2009) Hormone replacement therapy and cardiovascular disease revisited. Menopause Int 15:55-57
-
(2009)
Menopause Int
, vol.15
, pp. 55-57
-
-
Stevenson, J.C.1
-
18
-
-
0026458371
-
Hormone therapy to prevent disease and prolong life in postmenopausal women
-
Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037
-
(1992)
Ann Intern Med
, vol.117
, pp. 1016-1037
-
-
Grady, D.1
Rubin, S.M.2
Petitti, D.B.3
Fox, C.S.4
Black, D.5
Ettinger, B.6
-
19
-
-
0031016850
-
Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis
-
Adams MR, Register TC, Golden DL, Wagner JD, Williams JK (1997) Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 17:217-221 (Pubitemid 27057346)
-
(1997)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.17
, Issue.1
, pp. 217-221
-
-
Adams, M.R.1
Register, T.C.2
Golden, D.L.3
Wagner, J.D.4
Williams, J.K.5
-
20
-
-
0028937675
-
The metabolic and cardiovascular consequences of hormone replacement therapy
-
Stevenson J (1995) The metabolic and cardiovascular consequences of hormone replacement therapy. Br J Clin Pract 49:87-90
-
(1995)
Br J Clin Pract
, vol.49
, pp. 87-90
-
-
Stevenson, J.1
-
21
-
-
0029793964
-
Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen/progestin regimens
-
Taskinen MR, Puolakka J, Pyorala T, Luotola H, Bjaorn M, Kaarianen J et al (1996) Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen/progestin regimens. Arterioscler Thromb Vasc Biol 16:1215/21
-
(1996)
Arterioscler Thromb Vasc Biol
, vol.16
-
-
Taskinen, M.R.1
Puolakka, J.2
Pyorala, T.3
Luotola, H.4
Bjaorn, M.5
Kaarianen, J.6
-
22
-
-
0027958761
-
Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women
-
DOI 10.1016/S0140-6736(94)91117-7
-
Sack MN, Rader DJ, Cannon RO (1994) Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343:269-270 (Pubitemid 24039631)
-
(1994)
Lancet
, vol.343
, Issue.8892
, pp. 269-270
-
-
Sack, M.N.1
Rader, D.J.2
Cannon III, R.O.3
-
23
-
-
0343632564
-
Hormone replacement therapy and circulating ICAM-1 in postmenopausal women. A randomised controlled trial
-
Scarabin PY, Alhenc-Gelas M, Oger E, Plu-Bureau G (1999) Hormone replacement therapy and circulating ICAM-1 in postmenopausal women a randomised controlled trial. Thromb Haemost 81:673-675 (Pubitemid 29216547)
-
(1999)
Thrombosis and Haemostasis
, vol.81
, Issue.5
, pp. 673-675
-
-
Scarabin, P.-Y.1
Alhenc-Gelas, M.2
Oger, E.3
Plu-Bureau, G.4
-
24
-
-
0029011362
-
Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renninaldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism
-
Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R (1995) Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renninaldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. J Clin Endocrinol Metab 80:1816-1821
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 1816-1821
-
-
Oelkers, W.1
Foidart, J.M.2
Dombrovicz, N.3
Welter, A.4
Heithecker, R.5
-
25
-
-
77957126077
-
Effects of oestrogen or oestrogen:progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal oestrogen:progestin interventions (PEPI) trial
-
The Writing Group for the PEPI Trial
-
The Writing Group for the PEPI Trial (1995) Effects of oestrogen or oestrogen:progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal oestrogen:progestin interventions (PEPI) trial. J Am Med Assoc 273:199-208
-
(1995)
J Am Med Assoc
, vol.273
, pp. 199-208
-
-
-
26
-
-
0029827353
-
Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women
-
McCrohon JA, Adams MR, McCredie RJ et al (1996) Hormone replacement therapy is associated with improved arterial physiology in healthy postmenopausal women. Clin Endocrinol 45:435-441 (Pubitemid 26383421)
-
(1996)
Clinical Endocrinology
, vol.45
, Issue.4
, pp. 435-441
-
-
McCrohon, J.A.1
Adams, M.R.2
McCredie, R.J.3
Robinson, J.4
Pike, A.5
Abbey, M.6
Keech, A.C.7
Celermajer, D.S.8
-
27
-
-
33751111978
-
Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism
-
DOI 10.1016/j.maturitas.2006.07.009, PII S0378512206002829
-
Palacios S, Foidart JM, Genazzani AR (2006) Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism. Maturitas 55:297-307 (Pubitemid 44767795)
-
(2006)
Maturitas
, vol.55
, Issue.4
, pp. 297-307
-
-
Palacios, S.1
Foidart, J.-M.2
Genazzani, A.R.3
-
28
-
-
0037177150
-
Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen
-
DOI 10.1161/hc1202.105945
-
Wakatsuki A, Okatani Y, Ikenoue N, Fukukaya T (2002) Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen. Circulation 105:1436-1439 (Pubitemid 34263274)
-
(2002)
Circulation
, vol.105
, Issue.12
, pp. 1436-1439
-
-
Wakatsuki, A.1
Okatani, Y.2
Ikenoue, N.3
Fukaya, T.4
-
29
-
-
0036745779
-
Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception
-
Stanczyk FZ (2002) Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception. Rev Endocr Metab Disord 3:211-224
-
(2002)
Rev Endocr Metab Disord
, vol.3
, pp. 211-224
-
-
Stanczyk, F.Z.1
-
30
-
-
3242664107
-
Estradiol and drospirenone for climacteric symptoms in postmenopausal women: A double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens
-
DOI 10.1080/13697130410001713698
-
Schurmann R, Holler T, Benda N (2004) Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens. Climacteric 7:189-196 (Pubitemid 38951701)
-
(2004)
Climacteric
, vol.7
, Issue.2
, pp. 189-196
-
-
Schurmann, R.1
Holler, T.2
Benda, N.3
-
31
-
-
0037192310
-
Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration
-
DOI 10.1161/hc0402.102860
-
Campisi R, Nathan L, Pampaloni MH, Schöder H, Sayre JW, Chaudhuri G, Schelbert HR (2002) Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration. Circulation 105:425-430 (Pubitemid 34141697)
-
(2002)
Circulation
, vol.105
, Issue.4
, pp. 425-430
-
-
Campisi, R.1
Nathan, L.2
Pampaloni, M.H.3
Schoder, H.4
Sayre, J.W.5
Chaudhuri, G.6
Schelbert, H.R.7
-
32
-
-
0035666642
-
Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women
-
Duvernoy CS, Rattenhuber J, Seifert-Klauss V, Bengel F, Meyer C, Schwaiger M (2001) Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women. J Gender Specific Med 4:21-27
-
(2001)
J Gender Specific Med
, vol.4
, pp. 21-27
-
-
Duvernoy, C.S.1
Rattenhuber, J.2
Seifert-Klauss, V.3
Bengel, F.4
Meyer, C.5
Schwaiger, M.6
-
33
-
-
2942683377
-
Myocardial blood flow and flow reserve in response to hormone therapy in postmenopausal women with risk factors for coronary disease
-
DOI 10.1210/jc.2003-031674
-
Duvernoy C, Martin J, Briesmiester A, Bargardi A, Muzik O, Mosca L (2004) Myocardial blood flow and flow reserve in response to hormonetherapy in postmenopausal women with risk factors for coronary disease. J Clin Endocrinol Metab 89:2783-2788 (Pubitemid 38766366)
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, Issue.6
, pp. 2783-2788
-
-
Duvernoy, C.1
Martin, J.2
Briesmiester, K.3
Bargardi, A.4
Muzik, O.5
Mosca, L.6
-
34
-
-
33644987045
-
Effects of aldosterone on the vasculature
-
Schriffrin EL (2006) Effects of aldosterone on the vasculature. Hypertension 47:312-318
-
(2006)
Hypertension
, vol.47
, pp. 312-318
-
-
Schriffrin, E.L.1
-
35
-
-
0037417252
-
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
-
DOI 10.1056/NEJMoa030207
-
Pitt B, Remme W, Zannad F et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309-1321 (Pubitemid 36384098)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.14
, pp. 1309-1321
-
-
Pitt, B.1
Remme, W.2
Zannad, F.3
Neaton, J.4
Martinez, F.5
Roniker, B.6
Bittman, R.7
Hurley, S.8
Kleiman, J.9
Gatlin, M.10
-
36
-
-
1842867053
-
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy
-
The Women's Health Initiative Steering Committee
-
The Women's Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 291:1701-1712
-
(2004)
JAMA
, vol.291
, pp. 1701-1712
-
-
-
37
-
-
0025542315
-
Evaluation of the association between carotid artery atherosclerosis and coronary artery stenosis: A case control study
-
Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF (1990) Evaluation of the association between carotid artery atherosclerosis and coronary artery stenosis: a case control study. Circulation 82:1230-1242
-
(1990)
Circulation
, vol.82
, pp. 1230-1242
-
-
Craven, T.E.1
Ryu, J.E.2
Espeland, M.A.3
Kahl, F.R.4
McKinney, W.M.5
Toole, J.F.6
-
38
-
-
0028900413
-
Combined estrogen-progestin replacement therapy prevents atherosclerosis in postmenopausal women
-
Punnonen RH, Jokela HA, Dastiden PS, Wevelo M, Laippale PJ (1995) Combined estrogen-progestin replacement therapy prevents atherosclerosis in postmenopausal women. Maturitas 21:179-187
-
(1995)
Maturitas
, vol.21
, pp. 179-187
-
-
Punnonen, R.H.1
Jokela, H.A.2
Dastiden, P.S.3
Wevelo, M.4
Laippale, P.J.5
-
39
-
-
0030040153
-
Relation of intima-media thickness to atherosclerotic plaques in carotid arteries: The vascular aging (EVA) study
-
Bonithon-Kopp C, Toubout PJ, Berr C, Leroux C, Mainard F, Courbon D (1996) Telation of intima-media thickness to atherosclerotic plaques in carotid arteries. The vascular aging (E.U.A.) study. Arterioscler Thromb Vasc Biol 16:310-316 (Pubitemid 26056252)
-
(1996)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.16
, Issue.2
, pp. 310-316
-
-
Bonithon-Kopp, C.1
Touboul, P.-J.2
Berr, C.3
Leroux, C.4
Mainard, F.5
Courbon, D.6
Ducimetiere, P.7
-
40
-
-
0002600943
-
Prevalence of and risk factors for intimamedia thickening: A literature review
-
Touboul P-J, Crouse JR, (eds) Parthenon Publishing Group New York, NY
-
Bonithon-Kopp C (1997) Prevalence of and risk factors for intimamedia thickening: a literature review. In: Touboul P-J, Crouse JR, (eds), Intima-media thickness and atherosclerosis: predicting the risk? Parthenon Publishing Group New York, NY, pp 27-44
-
(1997)
Intima-media Thickness and Atherosclerosis: Predicting the Risk?
, pp. 27-44
-
-
Bonithon-Kopp, C.1
-
41
-
-
0033531215
-
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults
-
DOI 10.1056/NEJM199901073400103
-
O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research Group. N Engl J Med 340:14-22 (Pubitemid 29024679)
-
(1999)
New England Journal of Medicine
, vol.340
, Issue.1
, pp. 14-22
-
-
O'Leary, D.H.1
Polak, J.F.2
Kronmal, R.A.3
Manolio, T.A.4
Burke, G.L.5
Wolfson Jr., S.K.6
-
42
-
-
0030004901
-
Antiatherosclerotic effects of antihypertensive drugs: Recent evidence and ongoing trials
-
Zanchetti A (1996) Antiatherosclerotic effects of antihypertensive drugs: recent evidence and ongoing trials. Clin Exp Hypertens 18:489-499
-
(1996)
Clin Exp Hypertens
, vol.18
, pp. 489-499
-
-
Zanchetti, A.1
|